(Q34108976)

31 July 2017

1 reference

title

Antiphospholipid antibodies and the endothelium. (English)

1 reference

31 July 2017

0 references

2

Khamashta MA

1 reference

31 July 2017

Hunt BJ

1

1 reference

31 July 2017

publication date

1 June 2000

1 reference

Current Rheumatology Reports

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

252-255

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-000-0087-6

31 July 2017

exact match

0 references

cites work

Endothelial cell activation. A central pathophysiological process

1 reference

https://api.crossref.org/works/10.1007%2FS11926-000-0087-6

Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL. Involvement of nuclear factor-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-000-0087-6

Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-000-0087-6

Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-000-0087-6

Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology

21 January 2018

1 reference

12 December 2020

Regulation of the thrombotic potential of atheroma.

1 reference

12 December 2020

Can graft endothelial cells initiate a host anti-graft immune response?

1 reference

12 December 2020

The involvement of beta2-glycoprotein I (beta2-GPI) in human and murine atherosclerosis

1 reference

12 December 2020

Barriers to xenotransplantation

1 reference

12 December 2020

In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.

1 reference

12 December 2020

Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo

1 reference

12 December 2020

Antiendothelial Cell Antibodies in Patients with the Antiphospholipid Syndrome

1 reference

12 December 2020

Leucocyte-endothelial interactions and regulation of leucocyte migration.

1 reference

12 December 2020

The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome.

1 reference

12 December 2020

Histopathology of graft coronary disease

1 reference

12 December 2020

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

1 reference

12 December 2020

Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1

1 reference

12 December 2020

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

12 December 2020

Do antiphospholipid antibodies interfere with tissue factor pathway inhibitor?

1 reference

12 December 2020

Low density lipoprotein oxidation and its pathobiological significance

1 reference

12 December 2020

Characterization and specificity of anti-endothelial cell membrane antibodies and their relationship to thrombosis in primary antiphospholipid syndrome (APS)

1 reference

12 December 2020

Endothelial cells as target for antiphospholipid antibodies. Human Polyclonal and Monoclonal Anti-β2-Glycoprotein I Antibodies React In Vitro with Endothelial Cells Through Adherent β2-Glycoprotein I and Induce Endothelial Activation

1 reference

12 December 2020

Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody. Evidence for endothelial injury as the primary event

1 reference

12 December 2020

Aortic occlusion in systemic lupus erythematosus associated with antiphospholipid antibodies

1 reference

12 December 2020

Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I

1 reference

12 December 2020

Atherosclerosis — An Inflammatory Disease

1 reference

12 December 2020

Serial analysis of gene expression to assess the endothelial cell response to an atherogenic stimulus

1 reference

12 December 2020

Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation

1 reference

12 December 2020

Immunology of the antiphospholipid antibody syndrome

1 reference

12 December 2020

The fine structure of the vascular response in hapten-specific delayed hypersensitivity and contact dermatitis

1 reference

12 December 2020

Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides

1 reference

12 December 2020

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

12 December 2020

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

1 reference

12 December 2020

Cholesterol reduction yields clinical benefit: impact of statin trials

1 reference

12 December 2020

Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies

1 reference

12 December 2020

Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteins.

1 reference

12 December 2020

Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

1 reference

12 December 2020

Antiphospholipid arterial vasculopathy

1 reference

12 December 2020

10.1007/S11926-000-0087-6

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1018875752

0 references

1 reference